Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes

被引:43
|
作者
Persson, Martina [1 ,2 ]
Cnattingius, Sven [1 ]
Wikstrom, Anna-Karin [1 ,3 ]
Johansson, Stefan [1 ,2 ]
机构
[1] Karolinska Inst, Clin Epidemiol Unit, Dept Med Solna, Eugeniahemmet T2, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden
[3] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
BMI; Diabetestype; 1; Diabetes type 2; Moderate pre-eclampsia; Obesity; Overweight; Pre-eclampsia; Risk of pre-eclampsia; Severe pre-eclampsia; PREGNANCY-INDUCED HYPERTENSION; BODY-MASS INDEX; GLYCEMIC CONTROL; GESTATIONAL HYPERTENSION; NEPHROPATHY; POPULATION; OUTCOMES; EPIDEMIOLOGY;
D O I
10.1007/s00125-016-4035-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Women with type 1 or type 2 diabetes are at increased risk of pre-eclampsia. Overweight and obesity are associated with an increased risk of pre-eclampsia in women without diabetes. The aim of the study was to investigate the impact of maternal overweight and obesity on the risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes. MethodsIn a population-based cohort study including singleton births in Sweden, we estimated the risk of pre-eclampsia among women with type 1 diabetes (n = 7062) and type 2 diabetes (n = 886), and investigated whether maternal overweight (BMI 25-29.9 kg/m(2)) and obesity (BMI aeyen30.0 kg/m(2)) modified the risk. Logistic regression analyses were used to estimate crude and adjusted ORs with 95% CIs, using women without diabetes as the reference group (n = 1,509,525). Results Compared with women without diabetes, the adjusted ORs for pre-eclampsia in women with type 1 and type 2 diabetes were 5.74 (95% CI 5.31, 6.20) and 2.11 (95% CI 1.65, 2.70), respectively. The corresponding risks of pre-eclampsia combined with preterm birth were even higher. Risks of pre-eclampsia increased with maternal overweight (BMI 25-29.9 kg/m(2)) and obesity (BMI aeyen30.0 kg/m(2)), foremost in women without diabetes, to a lesser extent in women with type 1 diabetes but not in women with type 2 diabetes. Conclusions/interpretation Maternal overweight and obesity increased risks of pre-eclampsia in women with type 1 diabetes but not in women with type 2 diabetes. Even so, considering associations between maternal BMI and overall maternal and offspring risk, all women (with and without diabetes) should aim for a normal weight before pregnancy.
引用
收藏
页码:2099 / 2105
页数:7
相关论文
共 50 条
  • [1] Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes
    Martina Persson
    Sven Cnattingius
    Anna-Karin Wikström
    Stefan Johansson
    [J]. Diabetologia, 2016, 59 : 2099 - 2105
  • [2] FIRST TRIMESTER PREDICTION OF PRE-ECLAMPSIA IN WOMEN WITH TYPE 1 DIABETES
    Kelly, C.
    Hookham, M.
    Yu, J.
    Hanssen, K.
    Jenkins, A.
    Hammad, S.
    Aston, C.
    Lyons, T.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 592 - 592
  • [3] Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes
    Clare B. Kelly
    Michelle B. Hookham
    Jeremy Y. Yu
    Samuel M. Lockhart
    Mei Du
    Alicia J. Jenkins
    Alison Nankervis
    Kristian F. Hanssen
    Tore Henriksen
    Satish K. Garg
    Samar M. Hammad
    James A. Scardo
    Christopher E. Aston
    Christopher C. Patterson
    Timothy J. Lyons
    [J]. Diabetologia, 2017, 60 : 2514 - 2524
  • [4] Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes
    Kelly, Clare B.
    Hookham, Michelle B.
    Yu, Jeremy Y.
    Lockhart, Samuel M.
    Du, Mei
    Jenkins, Alicia J.
    Nankervis, Alison
    Hanssen, Kristian F.
    Henriksen, Tore
    Garg, Satish K.
    Hammad, Samar M.
    Scardo, James A.
    Aston, Christopher E.
    Patterson, Christopher C.
    Lyons, Timothy J.
    [J]. DIABETOLOGIA, 2017, 60 (12) : 2514 - 2524
  • [5] Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial
    Holmes, Valerie A.
    Young, Ian S.
    Patterson, Christopher C.
    Pearson, Donald W. M.
    Walker, James D.
    Maresh, Michael J. A.
    McCance, David R.
    [J]. DIABETES CARE, 2011, 34 (08) : 1683 - 1688
  • [6] Pre-eclampsia biomarkers for women with type 1 diabetes mellitus: a systematic review
    Freimane, K.
    Eastwood, K.
    Watson, C.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 : 170 - 170
  • [7] LRG1 as a predictive marker for pre-eclampsia in women with type 1 diabetes
    Cheung, A. H. Y.
    Jenkins, A. J.
    Hanssen, K. F.
    Garg, S. K.
    Yu, J. Y.
    Aston, C. E.
    Kelly, C. B.
    Lyons, T. J.
    Watson, C. J.
    [J]. DIABETOLOGIA, 2017, 60 : S428 - S428
  • [8] Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes
    Temple, R. C.
    Aldridge, V.
    Stanley, K.
    Murphy, H. R.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (11) : 1329 - 1332
  • [9] A study of the effect of glycaemic control and prepregnancy care on risk of pre-eclampsia in women with type 1 diabetes
    Temple, RC
    Aldridge, V
    Stanley, K
    Murphy, HR
    [J]. DIABETOLOGIA, 2005, 48 : A315 - A315
  • [10] Can activin A and inhibin A predict development of pre-eclampsia in women with type 1 diabetes?
    Mathiesen, ER
    Ekbom, P
    Skakkebæk, NE
    Andersson, AM
    Feldt-Rasmussen, U
    Damm, P
    [J]. DIABETOLOGIA, 2001, 44 : A247 - A247